Furthermore, an NF-ĸB inhibitor has recently been shown to achieve apoptosis induction with potential therapeutic value for CLL in cases with reduced expression of BIRC3 [26]. This evidence concerns the gene BIRC3 and B-cell chronic lymphocytic leukemia.